Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ansa Biotechnologies, a DNA synthesis technology spinout of University of California, Berkeley, has obtained $7.9m in a seed round led by Horizons Ventures that featured Mubadala Capital , the investment arm of Abu Dhabi state-owned Mubadala Investment, as well as Humboldt Fund and undisclosed additional investors. The company is working on a DNA synthesis method capable of building one DNA sequence base at a time, based on conjugating a template-independent polymerase enzyme to a single nucleoside triphosphate molecule. The funding…
